Next Article in Journal
Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future Directions
Previous Article in Journal
The Impact of the COVID-19 Pandemic on Psychological Health and Insomnia among People with Chronic Diseases
Review

Membranous Nephropathy: From Research Bench to Personalized Care

1
Department of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, 02-006 Warsaw, Poland
2
Department of Clinical Immunology, Medical University of Warsaw, 02-006 Warsaw, Poland
3
Department of Medicine, Division of Nephrology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
4
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Academic Editor: Radica Alicic
J. Clin. Med. 2021, 10(6), 1205; https://doi.org/10.3390/jcm10061205
Received: 26 January 2021 / Revised: 15 February 2021 / Accepted: 8 March 2021 / Published: 14 March 2021
(This article belongs to the Section Nephrology & Urology)
Membranous nephropathy is a glomerulopathy that causes nephrotic syndrome and, in at least a third of cases, lasting end-stage kidney disease (ESKD). It is also a rare case of revolutionary changes in our understanding of the disease, that translates from scientific findings to real diagnosis and treatment recommendations in less than ten years. In this review we present: (1) a short history and traditional approach to patients with membranous nephropathy, (2) current recommendations and treatment options that have emerged in recent years, (3) findings of new studies, with a particular focus on serological/immunological methods, genomic and proteomic studies, still requiring validation. With further development in this field, membranous nephropathy may become one of the first nephrological conditions that apply a truly personalized approach with the omission of invasive measures such as kidney biopsy. View Full-Text
Keywords: membranous nephropathy; glomerulonephritis; personalized medicine; PLA2R; proteomics membranous nephropathy; glomerulonephritis; personalized medicine; PLA2R; proteomics
Show Figures

Figure 1

MDPI and ACS Style

Moszczuk, B.; Kiryluk, K.; Pączek, L.; Mucha, K. Membranous Nephropathy: From Research Bench to Personalized Care. J. Clin. Med. 2021, 10, 1205. https://doi.org/10.3390/jcm10061205

AMA Style

Moszczuk B, Kiryluk K, Pączek L, Mucha K. Membranous Nephropathy: From Research Bench to Personalized Care. Journal of Clinical Medicine. 2021; 10(6):1205. https://doi.org/10.3390/jcm10061205

Chicago/Turabian Style

Moszczuk, Barbara, Krzysztof Kiryluk, Leszek Pączek, and Krzysztof Mucha. 2021. "Membranous Nephropathy: From Research Bench to Personalized Care" Journal of Clinical Medicine 10, no. 6: 1205. https://doi.org/10.3390/jcm10061205

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop